Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) EPS (Basic) (2021 - 2025)

PAVmed (PAVM) has 5 years of EPS (Basic) data on record, last reported at -$0.38 in Q3 2025.

  • For Q3 2025, EPS (Basic) changed N/A year-over-year to -$0.38; the TTM value through Sep 2025 reached $0.57, changed N/A, while the annual FY2024 figure was $3.3, 136.03% up from the prior year.
  • EPS (Basic) reached -$0.38 in Q3 2025 per PAVM's latest filing, up from -$1.01 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $1.28 in Q1 2025 and bottomed at -$14.25 in Q4 2022.
  • Average EPS (Basic) over 5 years is -$1.56, with a median of -$0.34 recorded in 2022.
  • Peak YoY movement for EPS (Basic): plummeted 6095.65% in 2022, then skyrocketed 148.85% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at -$0.23 in 2021, then tumbled by 6095.65% to -$14.25 in 2022, then soared by 86.53% to -$1.92 in 2023, then soared by 135.42% to $0.68 in 2024, then tumbled by 155.88% to -$0.38 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were -$0.38 in Q3 2025, -$1.01 in Q2 2025, and $1.28 in Q1 2025.